Among all the rapid changes in clinical research initiated by COVID-19, none is quite as intensely focused as vaccine development. Dr. Scott Treiber, Vice President, Strategic Development at Synteract, and Dr. Jeffrey Rosen, Chief Medical Officer at AMR, recently held a webinar on “Addressing the Rapidly Evolving Vaccine Development Landscape” to explore this fast evolution and share insights on how to stay ahead.

Dr. Treiber began by examining a brief history of vaccine development over time, noting how the industry has progressed and sharing how the successes and failures of the past are influencing the development of vaccines today — especially now, as the race to address the current pandemic is in full force. He tackled tough questions like how to guarantee the highest levels of safety while expediting a globally sought solution and how regulatory authorities are monitoring adverse events while striving to ensure quality, safety, and effectiveness.

After a quick exploration of the types of vaccines and benefits and drawbacks of each, Dr. Treiber and Dr. Rosen had an engaged discussion about the tenets of vaccine development, operational considerations, and logistical considerations and challenges. Rosen offered specific details about site selection challenges and solutions. Together, they discussed some of the specific challenges faced by COVID-19 vaccine development and offered a compelling look at expanding technologies and new considerations based on the rapid evolution of current events.

If you missed the livestream of this information-packed webinar, you can still listen to the discussion here.